Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 149

1.

Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D'Amico Intermediate and High Risk Radical Prostatectomy: A Multi-Institutional Study.

Preisser F, van den Bergh RCN, Gandaglia G, Ost P, Surcel CI, Sooriakumaran P, Montorsi F, Graefen M, van der Poel H, de la Taille A, Briganti A, Salomon L, Ploussard G, Tilki D; EAU-YAUWP.

J Urol. 2019 Aug 22:101097JU0000000000000504. doi: 10.1097/JU.0000000000000504. [Epub ahead of print]

PMID:
31437119
2.

Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival Outcomes.

Moschini M, Zamboni S, Soria F, Mathieu R, Xylinas E, Tan WS, Kelly JD, Simone G, Meraney A, Krishna S, Konety B, Mattei A, Baumeister P, Mordasini L, Montorsi F, Briganti A, Gallina A, Stabile A, Sanchez-Salas R, Cathelineau X, Rink M, Necchi A, Karakiewicz PI, Rouprêt M, Koupparis A, Kassouf W, Scherr DS, Ploussard G, Boorjian SA, Lotan Y, Sooriakumaran P, Shariat SF.

J Clin Med. 2019 Aug 9;8(8). pii: E1192. doi: 10.3390/jcm8081192.

3.

Variation in Positive Surgical Margin Status After Radical Prostatectomy for pT2 Prostate Cancer.

Tan WS, Krimphove MJ, Cole AP, Marchese M, Berg S, Lipsitz SR, Löppenberg B, Nabi J, Abdollah F, Choueiri TK, Kibel AS, Sooriakumaran P, Trinh QD.

Clin Genitourin Cancer. 2019 Oct;17(5):e1060-e1068. doi: 10.1016/j.clgc.2019.06.008. Epub 2019 Jun 19.

PMID:
31303561
4.

Retzius sparing robotic assisted radical prostatectomy vs. conventional robotic assisted radical prostatectomy: a systematic review and meta-analysis.

Phukan C, Mclean A, Nambiar A, Mukherjee A, Somani B, Krishnamoorthy R, Sridhar A, Rajan P, Sooriakumaran P, Rai BP.

World J Urol. 2019 May 14. doi: 10.1007/s00345-019-02798-4. [Epub ahead of print] Review.

PMID:
31089802
5.

Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration.

Zamboni S, Soria F, Mathieu R, Xylinas E, Abufaraj M, D Andrea D, Tan WS, Kelly JD, Simone G, Gallucci M, Meraney A, Krishna S, Konety BR, Antonelli A, Simeone C, Baumeister P, Mattei A, Briganti A, Gallina A, Montorsi F, Rink M, Aziz A, Karakiewicz PI, Rouprêt M, Koupparis A, Scherr DS, Ploussard G, Sooriakumaran P, Shariat SF, Moschini M; European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group.

BJU Int. 2019 May 4. doi: 10.1111/bju.14791. [Epub ahead of print]

PMID:
31055865
6.

Current concepts in oligometastatic prostate cancer: Is there a role for radical prostatectomy?

Marenco J, Sooriakumaran P.

Arch Esp Urol. 2019 Mar;72(2):174-181. Review.

PMID:
30855019
7.

PEOPLE: PatiEnt prOstate samPLes for rEsearch, a tissue collection pathway utilizing magnetic resonance imaging data to target tumor and benign tissue in fresh radical prostatectomy specimens.

Heavey S, Costa H, Pye H, Burt EC, Jenkinson S, Lewis GR, Bosshard-Carter L, Watson F, Jameson C, Ratynska M, Ben-Salha I, Haider A, Johnston EW, Feber A, Shaw G, Sridhar A, Nathan S, Rajan P, Briggs TP, Sooriakumaran P, Kelly JD, Freeman A, Whitaker HC.

Prostate. 2019 May;79(7):768-777. doi: 10.1002/pros.23782. Epub 2019 Feb 26.

8.

Pathological Findings and Magnetic Resonance Imaging Concordance at Salvage Radical Prostatectomy for Local Recurrence following Partial Ablation Using High Intensity Focused Ultrasound.

Thompson JE, Sridhar AN, Tan WS, Freeman A, Haider A, Allen C, Moore CM, Orczyk C, Mazzon G, Khetrapal P, Shaw G, Rajan P, Mohammed A, Briggs TP, Nathan S, Kelly JD, Sooriakumaran P.

J Urol. 2019 Jun;201(6):1134-1143. doi: 10.1097/JU.0000000000000135.

PMID:
30730409
9.

Perioperative and oncological outcomes of radical prostatectomy for high-risk prostate cancer in the UK: an analysis of surgeon-reported data.

Aning JJ, Reilly GS, Fowler S, Challacombe B, McGrath JS, Sooriakumaran P; BAUS Section of Oncology.

BJU Int. 2019 Sep;124(3):441-448. doi: 10.1111/bju.14687. Epub 2019 Jun 10.

PMID:
30681267
10.

Surgery Versus Radiation for High-risk Prostate Cancer: The Fight Continues. But Is It Time To Call a Draw and Reach Consensus?

Sooriakumaran P, Pavan N, Wiklund PN, Roach M 3rd.

Eur Urol. 2019 Apr;75(4):556-557. doi: 10.1016/j.eururo.2018.12.032. Epub 2019 Jan 11. No abstract available.

PMID:
30639140
11.

Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study.

Soria F, Moschini M, D'andrea D, Abufaraj M, Foerster B, Mathiéu R, Gust KM, Gontero P, Simone G, Meraney A, Krishna S, Konety B, Rouprêt M, Perry M, Rowe E, Ploussard G, Boorjian SA, Wiklund P, Sooriakumaran P, Shariat SF.

Eur Urol Focus. 2018 Nov 16. pii: S2405-4569(18)30334-1. doi: 10.1016/j.euf.2018.11.002. [Epub ahead of print]

PMID:
30455153
12.

Propensity-score-matched comparison of soft tissue surgical margins status between open and robotic-assisted radical cystectomy.

Moschini M, Soria F, Mathieu R, Xylinas E, D'Andrea D, Tan WS, Kelly JD, Simone G, Tuderti G, Meraney A, Krishna S, Konety B, Zamboni S, Baumeister P, Mattei A, Briganti A, Montorsi F, Galucci M, Rink M, Karakiewicz PI, Rouprêt M, Aziz A, Perry M, Rowe E, Koupparis A, Kassouf W, Scherr DS, Ploussard G, Boorjian SA, Sooriakumaran P, Shariat SF; European Association of Urology – Young Academic Urologists (EAU-YAU), Urothelial Carcinoma Working Group.

Urol Oncol. 2019 Mar;37(3):179.e1-179.e7. doi: 10.1016/j.urolonc.2018.10.012. Epub 2018 Nov 14.

PMID:
30446442
13.

Comparison of Prostate Biopsy with or without Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Detection: An Observational Cohort Study.

Bryant RJ, Hobbs CP, Eyre KS, Davies LC, Sullivan ME, Shields W, Sooriakumaran P, Verrill CL, Gleeson FV, MacPherson RE, Hamdy FC, Brewster SF.

J Urol. 2019 Mar;201(3):510-519. doi: 10.1016/j.juro.2018.09.049.

PMID:
30266332
14.

Partial ablation versus radical prostatectomy in intermediate-risk prostate cancer: the PART feasibility RCT.

Hamdy FC, Elliott D, le Conte S, Davies LC, Burns RM, Thomson C, Gray R, Wolstenholme J, Donovan JL, Fitzpatrick R, Verrill C, Gleeson F, Singh S, Rosario D, Catto JW, Brewster S, Dudderidge T, Hindley R, Emara A, Sooriakumaran P, Ahmed HU, Leslie TA.

Health Technol Assess. 2018 Sep;22(52):1-96. doi: 10.3310/hta22520.

15.

Imaging modalities in synchronous oligometastatic prostate cancer.

Futterer JJ, Surcel C, van den Bergh R, Borgmann H, Briganti A, Gandaglia G, Kretschmer A, Ost P, Sooriakumaran P, Tilki D, Valerio M, Ploussard G, De Visschere PJL, Tsaur I; EAU-YAU Prostate Cancer Working Party.

World J Urol. 2018 Aug 1. doi: 10.1007/s00345-018-2416-2. [Epub ahead of print]

PMID:
30069582
16.

Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies?

Ploussard G, Borgmann H, Briganti A, de Visschere P, Fütterer JJ, Gandaglia G, Heidegger I, Kretschmer A, Mathieu R, Ost P, Sooriakumaran P, Surcel C, Tilki D, Tsaur I, Valerio M, van den Bergh R; EAU-YAU Prostate Cancer Working Group.

World J Urol. 2019 Feb;37(2):243-251. doi: 10.1007/s00345-018-2399-z. Epub 2018 Jul 2. Review.

PMID:
29967944
17.

Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer.

Elliott D, Hamdy FC, Leslie TA, Rosario D, Dudderidge T, Hindley R, Emberton M, Brewster S, Sooriakumaran P, Catto JWF, Emara A, Ahmed H, Whybrow P, le Conte S, Donovan JL.

BJU Int. 2018 Dec;122(6):970-977. doi: 10.1111/bju.14432. Epub 2018 Aug 15.

18.

How can we expand active surveillance criteria in patients with low- and intermediate-risk prostate cancer without increasing the risk of misclassification? Development of a novel risk calculator.

Gandaglia G, van den Bergh RCN, Tilki D, Fossati N, Ost P, Surcel CI, Sooriakumaran P, Tsaur I, Valerio M, Kretschmer A, Zaffuto E, Salomon L, Montorsi F, Graefen M, van der Poel H, de la Taille A, Briganti A, Ploussard G; European Association of Urology Young Academic Urologists Working Party on Prostate Cancer (EAU-YAUWP).

BJU Int. 2018 Nov;122(5):823-830. doi: 10.1111/bju.14391. Epub 2018 Jun 3.

19.

Does the introduction of prostate multiparametric magnetic resonance imaging into the active surveillance protocol for localized prostate cancer improve patient re-classification?

Bryant RJ, Yang B, Philippou Y, Lam K, Obiakor M, Ayers J, Chiocchia V, Gleeson F, MacPherson R, Verrill C, Sooriakumaran P, Hamdy FC, Brewster SF.

BJU Int. 2018 Nov;122(5):794-800. doi: 10.1111/bju.14248. Epub 2018 May 9.

20.

Are clinical guidelines designed according to guidelines? Cross-sectional assessment of quality and transparency of clinical guidelines in urology.

van den Bergh RCN, Ost P, Surcel C, Valerio M, Fütterer JJ, Gandaglia G, Sooriakumaran P, Tilki D, Tsaur I, Ploussard G; European Association of Urology Working Party on Prostate Cancer (EAU-YAUWP).

World J Urol. 2018 Sep;36(9):1489-1494. doi: 10.1007/s00345-018-2278-7. Epub 2018 Apr 2.

PMID:
29610962

Supplemental Content

Loading ...
Support Center